Lori J. Goldstein
0000-0002-6542-3421
Publication & Citation Trends
Publications
0 total
Updates in the Pathology and Therapy of BRCA Germline–Associated Breast Cancer with a Focus on HER2 Amplification
Cited by 0
Semantic Scholar
Psychosocial needs of older patients with metastatic breast cancer treated at community centers OA
Cited by 7
Semantic Scholar
Breast Cancer
Cited by 10
Semantic Scholar
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer (S1416): a randomised, phase 2 trial OA
Cited by 65
Semantic Scholar
Abstract B119: Effect of a smart pill bottle and text messaging-based intervention on medication adherence and side effect management in African American women with breast cancer new to endocrine therapy
Cited by 0
Semantic Scholar
Abstract GS1-04: Patient-reported cognitive impairment in women participating in the RxPONDER trial (SWOG S1007) by menopausal status
Cited by 2
Semantic Scholar
Abstract GS1-01: Race and clinical outcomes in the RxPONDER Trial (SWOG S1007)
Cited by 11
Semantic Scholar
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. OA
Cited by 410
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(140)
Cancer Treatment and Pharmacology
(79)
HER2/EGFR in Cancer Research
(65)
Advanced Breast Cancer Therapies
(49)
BRCA gene mutations in cancer
(28)
Affiliations
Northwestern University
University of Southern California
The Graduate Center, CUNY
University of Modena and Reggio Emilia
Indiana University Health
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.